Page last updated: 2024-10-31

mianserin and Autoimmune Diseases

mianserin has been researched along with Autoimmune Diseases in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uenishi, S1
Takahashi, S1
Nakayama, Y1
Hiwatani, Y1
Nakane, S1
Tsuji, T1
Ukai, S1

Other Studies

1 other study available for mianserin and Autoimmune Diseases

ArticleYear
A case of autoimmune autonomic ganglionopathy with prolonged delirium.
    Asian journal of psychiatry, 2019, Volume: 39

    Topics: Adrenergic alpha-Antagonists; Aged; Antipsychotic Agents; Autoimmune Diseases; Autonomic Nervous Sys

2019